Brief: Yumanity Therapeutics Reports Q1 2022 Results
12/05/2022 21:47
May 12 (Reuters) - Yumanity Therapeutics Inc YMTX.O :
* YUMANITY THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND RECENT CORPORATE DEVELOPMENTS
* Q1 LOSS PER SHARE $1.24
Source text for Eikon: ID:nGNX3FStCm
Further company coverage: YMTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study